Medifast (MED) Misses Q4 EPS by 8c, Guidance Mixed

Medifast (NYSE: MED) reported Q4 EPS of $0.38, $0.08 worse than the analyst estimate of $0.46. Revenue for the quarter came in at $62.3 million versus the consensus estimate of $69.4 million.

Medifast sees FY2015 EPS of $1.85-$1.95, versus the consensus of $1.83. Medifast sees FY2015 revenue of $285-300 million, versus the consensus of $307.77 million.

Medifast sees Q1 2015 EPS of $0.33-$0.35, versus the consensus of $0.43. Medifast sees Q1 2015 revenue of $70-73 million, versus the consensus of $83.70 million.

For earnings history and earnings-related data on Medifast (MED) click here.

You May Also Be Interested In

• Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
• Ovintiv Inc. (OVV) Tops Q3 EPS by 3c
• Bristow Group (VTOL) Misses Q2 EPS by 24c ; Offers Guidance